X hits on this document

Word document

The usefulness and use of second-generation - page 59 / 81

185 views

0 shares

0 downloads

0 comments

59 / 81

238 Cheine M, Ahonen J, Wahlbeck K. Beta-blocker supplementation of standard drug treatment for schizophrenia. Cochrane Database Syst Rev 2001; CD000234.

239 Naber D. Long-term phase of schizophrenia: impact of atypical agents. Int Clin Psychopharmacol 2000; 15 (Suppl 4):S11-S14.

240 Saleem P, Olie JP, Loo H. Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride. Int Clin Psychopharmacol 2002; 17:1-8.

APPENDIX 1

LIST OF MEMBERS OF THE TASK FORCE

Dr W. Wolfgang Fleischhacker, Professor of Psychiatry, Department of Psychiatry, Innsbruck University Clinics, Anichstrasse 35, A-6020 Innsbrück, Austria

Dr Annette Gjerris, Professor and Chair, Department of Psychiatry, Gentofte University Hospital, Niels Andersens Vej 65, 2900 Hellerup, Denmark

Dr Ursula Kern, Director and Professor, Head of Neurology, Psychiatry, Anaesthesiology,Addiction, Clinical Pharmacology II, Federal Institute for Drugs and Medical Devices Seestrasse 10, D-13353 Berlin, Germany

Dr Martin Knapp, Professor, Personal Social Services Research Unit, London School of Economics and Political Sciences, Houghton Street, London WC2A 2AE, United Kingdom

Dr Brian E. Leonard, Professor of Pharmacology, National University of Ireland, Galway, Ireland

Dr Jeffrey Lieberman, Thad and Alice Eure Distinguished Professor of Psychiatry, Pharmacology and Radiology University of North Carolina School of Medicine, 7025 Neurosciences Hospital, CB7160 Chapel Hill, NC 27599-7160, USA

Dr Juan J. López-Ibor, Professor of Psychiatry, President, World Psychiatric Association,Clinica Lopez-Ibor,  C./Nueva Zelanda, 44, E-28035 Madrid, Spain

Mr Bas van Raay, President, EUFAMI, Siegersteeg 2, 7734 PG Vilsteren, The Netherlands

Dr Norman Sartorius, Professor, HUG Hôpitaux Universitaires de Genève, Belle-Idée, Bâtiment Le Salève, 2 chemin du Petit-Bel-Air, CH-1225 Chêne-Bourg/Geneva, Switzerland  (Chairman of the Task Force)

Document info
Document views185
Page views185
Page last viewedSun Dec 04 11:23:23 UTC 2016
Pages81
Paragraphs1517
Words24865

Comments